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OBJECTIVES The aim of this study was to evaluate the viral etiology of idiopathic dilated cardiomyopathy
(DCM).
BACKGROUND The demonstration of enteroviral genome in hearts with DCM has reinforced the importance
of enteroviruses in the pathogenesis of DCM. However, there is uncertainty about the
character and activity of enteroviruses detected in the myocardium. Recently, the association
of hepatitis C virus or adenovirus with DCM has been reported.
METHODS Myocardial specimens from 26 patients with idiopathic DCM, which were obtained at partial
left ventriculectomy (PLV), were examined virologically. Strand-specific detection of entero-
viral RNA was performed to differentiate active viral replication from latent persistence.
Polymerase chain reaction was used to detect genomic sequences of hepatitis C virus,
adenovirus, cytomegalovirus, influenza viruses, mumps virus, herpes simplex viruses, varicella-
zoster virus and Epstein-Barr virus.
RESULTS Plus-strand enteroviral RNA was detected in 9 (35%) of the 26 patients. Minus-strand
enteroviral RNA was determined in seven (78%) of these nine plus-strand RNA-positive
patients. Sequence analysis revealed that the enteroviruses detected were coxsackie B viruses,
such as coxsackievirus B3 and B4. However, genetic material from other viruses was not
detected. Six (86%) of seven minus-strand enteroviral RNA-positive patients died of cardiac
insufficiency within the first six months after PLV.
CONCLUSIONS Coxsackie B viruses were seen in hearts with idiopathic DCM. Active viral RNA replication
appeared to be present in a significant proportion of these cases. Minus-strand coxsackieviral
RNA in the myocardium can be a marker for poor clinical outcome after PLV. There was no
evidence of persistent infection by other viruses in hearts with DCM. (J Am Coll Cardiol
2000;36:1920–6) © 2000 by the American College of Cardiology
Enteroviruses have been implicated in the pathogenesis of
idiopathic dilated cardiomyopathy (DCM) (1). This notion
was supported originally by the long-term outcomes of some
patients with acute myocarditis (2,3), retrospective serologic
tests of viral antibodies (4–6) and studies of animal models
(7–9). The demonstration of enteroviral RNA in hearts
with DCM using slot blot (10), in situ hybridization (11)
and polymerase chain reaction (PCR) (12,13) reinforced the
importance of enteroviruses in the pathogenesis of DCM.
However, more recent studies by PCR have yielded con-
flicting results. There was considerable variation in entero-
viral positivity in hearts with DCM (14–22). In addition,
there is uncertainty about the character of enteroviral
genome detected in the myocardium. Considerable efforts
have been made to clarify the nature of enteroviral genomes
detected in hearts with DCM. Polymerase chain reaction
with genotype-specific primers (16), stringent hybridization
assay with genotype-specific probes (23), restriction enzyme
digestion of PCR products (19), PCR single-strand confor-
mation polymorphism (20) and nested PCR (N-PCR)
followed by nucleotide sequence analysis (18,21,22) were
used and provided limited information. Clarification of the
genotypes of detected enteroviruses is the most important
issue to be resolved in order to investigate the enteroviral
etiology of DCM. Another point of interest is enteroviral
activity in myocardium from patients with DCM. The
differentiation between active enteroviral replication and
latent persistence in the myocardium is considered to be
important in view of the pathogenecity and management of
this disease.
Links between cytomegalovirus or hepatitis C virus and
DCM were reported (24,25). Recently, adenoviral DNA
was detected in a significant proportion of pediatric patients
with myocarditis (26) and in adult patients with DCM (27).
However, subsequent studies, including molecular detection
of these viruses in the myocardium, have not been per-
formed. Because other viruses can also induce myocarditis
(28), there is a possibility that other potentially cardiotropic
viruses are associated with DCM. Therefore, it is necessary
to examine whether other viruses or viral genomes can be
demonstrated in the myocardium of patients with this
disease.
Endomyocardial specimens have been primarily used for
the detection of viral genomes (10–22,24–27). Because of
the small size of myocardial samples, detailed virological
studies, including the detection of a variety of viruses and
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viral genomes, and the characterization of detected viruses
have been difficult. In this study very large myocardial
specimens obtained by partial left ventriculectomy (PLV)
(29,30) were examined virologically to determine the viral
etiology of idiopathic DCM. First, strand-specific detection
of enteroviral RNA was carried out to differentiate between
active enteroviral replication and latent persistence in DCM
hearts. Sequence analysis of PCR products was also per-
formed to characterize detected enteroviral genomes. Then
we attempted to detect other potentially cardiotropic viruses
including hepatitis C virus, adenovirus, cytomegalovirus,
influenza viruses, mumps virus, herpes simplex viruses,
varicella-zoster virus and Epstein-Barr virus by reverse
transcription PCR (RT-PCR) or PCR. Another goal of this
study was to determine the relationship between virological
findings and the early prognosis of patients with idiopathic
DCM after PLV.
METHODS
Patient population. Twenty-eight consecutive patients
with idiopathic DCM who underwent PLV between April
1997 and October 1998 at the Shonan Kamakura General
Hospital or Osaka Medical College Hospital were enrolled
in this study. The clinical diagnosis of DCM was made
according to the World Health Organization/International
Society and Federation of Cardiology task force (31).
Assessment of the symptoms of heart failure was performed
using the New York Heart Association (NYHA) functional
classification (32). All patients underwent noninvasive and
invasive evaluation, including echocardiography (M mode,
two-dimensional and Doppler) and cardiac catheterization
with coronary angiography. Institutional review board ap-
proval was obtained at both hospitals, and all patients gave
informed consent for inclusion in the study. All surgery was
successfully carried out using the procedure described by
Batista (29). All myocardial specimens resected during PLV
were subjected to histopathological examination by light
and electron microscopy and histochemistry. All samples
were immediately snap-frozen in liquid nitrogen and stored
at 280°C until use for the detection of viral genomes. Left
ventricular specimens from 21 normal individuals (15 men
and 6 women; mean age, 49 6 18 years) who died of
noncardiac causes served as control specimens. They had
normal histologic findings, and there was no evidence of
cardiac viral infection. Left ventricular specimens from 15
patients (13 men and 2 women; mean age, 62 6 15 years)
who underwent aneurysmectomy or Dor’s operation (33)
were also studied.
Detection of viral genome. Total RNA and genomic/viral
DNA were extracted from individual homogenates of myo-
cardial specimens using ABI-340A Nucleic Acid Extractor
(Applied Biosystems, Foster City, California) according to
the standard program supplied by the manufacturer. Primer
pairs to amplify the genomic sequences of the enterovirus
(34) including coxsackie A and B viruses, echoviruses and
polioviruses, hepatitis C virus (35), influenza A and B
viruses (36), mumps virus (37), adenovirus (38), cytomega-
lovirus (39), herpes simplex 1 and 2 viruses, varicella-zoster
virus (40) and Epstein-Barr virus (41) have been described
previously. These primers were designed to amplify most
virus types within their genus. Five mg of extracted total
RNA was used for each viral first complementary DNA
(cDNA) synthesis. Strand-specific viral RNA detection was
performed for enterovirus (34) and hepatitis C virus (35).
Conventional RT-PCR was used for the detection of
genomic nucleic acid of mumps virus and influenza A and B
viruses. For the detection of genomic nucleic acid of DNA
viruses (adenovirus, cytomegalovirus, herpes simplex 1 and 2
viruses, varicella-zoster virus and Epstein-Barr virus), 10 mg
of extracted DNA was used. Synthesis of viral first cDNA,
PCR amplification of cDNA and Southern blot hybridiza-
tion of the PCR products were performed as reported
previously (34–41).
Independent RT-PCR and PCR were performed on each
sample with beta-actin primers to evaluate a sufficient
amount of extracted RNA and DNA (42). Several negative
controls were included in each reaction. Extraction of total
RNA and genomic/viral DNA, synthesis of viral first
cDNA, PCR amplification of cDNA and Southern blot
hybridization were performed in different rooms with sep-
arate equipment and pipettes.
Sequence analysis of the PCR product. Polymerase chain
reaction amplified part of the 59 noncoding region of the
enteroviral genome (12), which is available for genotyping
of enteroviruses (43). Polymerase chain reaction amplifica-
tion products derived from DCM patients were visualized
by agarose gel electrophoresis at ethidium bromide staining.
Polymerase chain reaction products were gel-isolated and
purified for sequencing using the Concert Gel Extraction
Systems (Gibco-GRL, Rockville, Maryland). The nucleo-
tide sequences were determined in each direction using an
automated DNA sequencer with fluorescent dideoxy-chain
terminators (PE-Applied Biosystems, Foster City, Califor-
nia) with the same primers that were used for PCR (12).
The sequences were compared with all DNA sequences by
FASTA search of GenBank database.
Virus isolation. Myocardial samples were homogenized in
viral transport media, and the supernatant was used to
inoculate susceptible cell lines for the isolation of viruses.
The cell cultures were then incubated at 37°C and observed
daily for 21 days for cytopathic effect.
Abbreviations and Acronyms
cDNA 5 complementary DNA
DCM 5 dilated cardiomyopathy
N-PCR 5 nested polymerase chain reaction
NYHA 5 New York Heart Association
PCR 5 polymerase chain reaction
PLV 5 partial left ventriculectomy
RT-PCR 5 reverse transcription polymerase
chain reaction
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Viral genome and clinical outcomes. The results of viral
genomes were compared with the clinical outcomes within
one year after PLV. The clinical variables between virus
genome-positive and virus genome-negative patients were
also analyzed.
Statistical analysis. Statistica 5.1 statistical software was
used for statistical analysis. Significance was determined by
Fisher exact test or Student t test. A value of p , 0.05 was
considered significant.
RESULTS
Clinical presentation. Two enrolled patients were found
to have cardiac sarcoidosis and mitochondrial cardiomyop-
athy by histological examination of the resected myocar-
dium and were excluded from further analysis. The remain-
ing 26 patients (20 men and 6 women; mean age, 48 6 15
years) were selected for this study. Seven patients were
NYHA class III and 19 were NYHA class IV. All patients
had enlarged left ventricular end-diastolic diameter and
global left ventricular dysfunction assessed by echocardiog-
raphy; mean left ventricular end-diastolic diameter was
80 6 10 mm; mean left ventricular ejection fraction was
18 6 7%. Angiography detailed no evidence of coronary
disease. No patients had hypertension, drug or alcohol
abuse, ischemic heart disease or systemic disorders. All
specimens had a histological appearance consistent with a
diagnosis of idiopathic DCM.
Detection of viral genome. First, strand-specific enterovi-
ral RNA detection was performed to differentiate active
viral replication and latent persistence. Figure 1 shows a
representative Southern blot hybridization analysis of the
amplified PCR products. Plus-strand enteroviral RNA was
detected in 9 (35%) of the 26 patients. In seven (78%) of
these nine plus-strand positive patients, minus-strand en-
teroviral RNA was demonstrated. However, genetic mate-
rials from hepatitis C virus, influenza viruses, mumps virus,
adenovirus, cytomegalovirus, herpes simplex viruses,
varicella-zoster virus and Epstein-Barr virus were not de-
tected. No viral genomes were demonstrated in the control
specimens. The PCR results for each virus were negative in
all negative controls. All samples were assayed from the
initial extraction of RNA and DNA at least three times and
yielded the same PCR results. All samples were positive for
the presence of beta-actin sequences by RT-PCR and PCR,
indicating the successful extraction of both RNA and DNA.
Sequence analysis of enteroviral PCR product. Nucleo-
tide sequence data were obtained on the 155 bp PCR
products, a part of the 59 noncoding region of the entero-
viral genome. Figure 2 shows the sequence data from the
patients with DCM. The amplified sequence from patient 1
was identical to that of coxsackievirus B3, strain Nancy. The
sequence from patient 3 had the highest homology (99.6%)
with that of coxsackievirus B4, strain J.V.B. In this case, one
base substitution at position 546 (G to C) was recognized.
In three cases (Patients 2, 6 and 7), the sequence exhibited
significant homology (94.2%) with that of clinically isolated
coxsackievirus B3 (44). Sequencing of the PCR products
from the remaining five hearts was incomplete and resem-
bled coxsackie B viruses.
Virus isolation. No viruses were isolated in cell culture by
conventional methods in any of the hearts with DCM or
control specimens.
Enteroviral genome and clinical outcome. Table 1 sum-
marizes the enteroviral PCR results and clinical outcomes
after PLV. Within one year after surgery, 17 of the 26
patients were alive, and most of them showed alleviation of
their clinical symptoms. Six (67%) of the nine enterovirus-
positive patients died of cardiac insufficiency within the first
six months after PLV. These six patients had minus-strand
enteroviral RNA in the myocardium. Therefore, six (86%)
of the seven minus-strand enterovirus RNA-positive pa-
tients died of cardiac insufficiency within the first six
months after PLV. However, 4 (24%) of the 17 enteroviral-
negative patients and 4 (21%) of the 19 minus-strand
RNA-negative patients died within a year after PLV.
Mortality was statistically greater in enterovirus-positive
patients than it was in enterovirus-negative patients (p 5
0.0425). Minus-strand enterovirus RNA-positive patients
had a particularly increased mortality rate compared with
minus-strand RNA-negative patients (p 5 0.0053). Clinical
variables were compared between enterovirus RNA-positive
and enterovirus RNA-negative patients. There were no
significant differences in any clinical criteria between the
two groups (Table 2).
DISCUSSION
Dilated cardiomyopathy is a myocardial disease character-
ized by ventricular dilation and impaired contractility with a
poor prognosis. Partial left ventriculectomy was introduced
Figure 1. Representative Southern blot hybridization analysis of enterovi-
ral polymerase chain reaction products. Strand-specific enteroviral RNA
detection in the myocardium from four different patients is shown. In lanes
3, 5, 7 and 9, RT-PCR was performed with 39 enteroviral primer for RT.
The signals seen in lanes 5 and 9 correspond to enteroviral plus-strand
cDNA. In lanes 4, 6, 8 and 10, RT-PCR was carried out with 59
enteroviral primer for RT. The signal seen in lane 6 corresponds to
enteroviral minus-strand cDNA. In summary, Patient 1 (lanes 5 and 6)
shows active enteroviral replication (minus-strand detectable). Patient 9
(lanes 9 and 10) shows latent virus persistence (not minus-strand detect-
able). Patient 11 (lanes 3 and 4) and Patient 18 (lanes 7 and 8) are negative
for enteroviral genome. Lane 1 5 positive control of coxsackie B1 cloned
DNA. Lane 2 5 negative control. Patients No. 1, 9, 11 and 18; see Table
1. cDNA 5 complementary DNA; RT-PCR 5 reverse transcription
polymerase chain reaction.
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for the treatment of refractory DCM (29) and has received
increasing worldwide attention (30). In this study using
large myocardial samples obtained at PLV, detailed virolog-
ical examination of hearts with idiopathic DCM was carried
out to evaluate the viral etiology of DCM.
Detection and identification of enteroviral genome.
First, enteroviral RNA was detected in 9 (35%) of the 26
patients with DCM. This incidence was relatively high
compared with enteroviral positivity using endomyocardial
biopsy samples in our laboratory (13,20) and others (12,14–
Figure 2. Alignment of nucleotide sequences of enterovirus polymerase chain reaction products derived from the myocardium of patients with idiopathic
dilated cardiomyopathy (Patients No. 1, 2, 3, 6 and 7; see Table 1). Published sequences of coxsackievirus B3 (strain Nancy), coxsackievirus B3 (clinical
isolate) and coxsackievirus B4 (strain J.V.B.) are shown in full, and any differences between these are indicated below by the presence of that base. A 5
adenine; C 5 cytocine; G 5 guanine; T 5 thymine; CVB3 5 coxsackievirus B3 (strain Nancy); CVB4 5 coxsackievirus B4 (strain J.V.B.); wCVB3 5
coxsackievirus B3 (clinical isolate).




1 14 M 1 1 Died
2 53 M 1 1 Died
3 16 M 1 1 Died
4 65 M 1 1 Died
5 64 F 1 1 Died
6 36 M 1 1 Died
7 56 M 1 1 Alive
8 42 M 1 2 Alive
9 40 M 1 2 Alive
10 22 F 2 2 Died
11 61 M 2 2 Died
12 51 F 2 2 Died
13 49 M 2 2 Died
14 48 F 2 2 Alive
15 55 M 2 2 Alive
16 60 M 2 2 Alive
17 47 M 2 2 Alive
18 65 M 2 2 Alive
19 57 F 2 2 Alive
20 55 M 2 2 Alive
21 25 M 2 2 Alive
22 57 F 2 2 Alive
23 38 M 2 2 Alive
24 67 M 2 2 Alive
25 50 M 2 2 Alive
26 48 M 2 2 Alive
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19). Several factors exist that affect the frequency of entero-
viral RNA such as differences in patient demography, stage
of the disease and a difference in the detection method.
However, this relatively high incidence of enteroviral RNA
may be due to the size of the myocardial specimens
examined. In situ hybridization studies showed uneven
distribution of enteroviral RNA signals in the myocardium
(11). In fact, an increased rate of enteroviral detection using
multiple biopsy samples compared with those obtained with
a single sample was reported (17). Therefore, the use of
adequately sized samples is considered to be necessary to
accurately determine the true frequency of enteroviral RNA
in hearts with DCM. A significant rate of enteroviral RNA
in the myocardium of patients with idiopathic DCM
emphasizes the importance of enteroviruses as etiological
agents of this disease.
Serological evidence indicates the presence of specific
enteroviral serotypes (especially coxsackie B viruses) in
hearts with DCM (4–6). However, there remains uncer-
tainty concerning the types of enteroviral genomes detected
in hearts with DCM. Several molecular biological tech-
niques were used to differentiate detected enteroviral ge-
nomes (16,19,20,23). However, sequencing the enteroviral
PCR products is most informative and can confirm the
origin of the viruses. Three papers included sequence data
on PCR products for patients with DCM (18,21,22). Two
studies have drawn attention to the danger of contamination
in N-PCR-based assay (18,21). Only Archard et al. (22)
reported that the sequence of enteroviral N-PCR products
had the highest homology with coxsackie B viruses. How-
ever, the study did not mention the specific types within the
coxsackie B viruses. We demonstrated here, by nucleotide
sequence analysis of one-stage PCR product, that viruses
detected in hearts with DCM were coxsackie B viruses, such
as coxsackievirus B3 and B4. Genomes of echovirus, cox-
sackie A virus and poliovirus were not detected, and the
involvement of these viruses in hearts with DCM was
deniable. Further investigation should, therefore, focus on
coxsackie B viruses to elucidate the molecular basis of
cardiotropism and pathogenesis.
Enteroviral activity in hearts with DCM. Transcription
of minus-strand RNA from the plus-strand enteroviral
genomic template is the essential first step of enteroviral
replication. This minus-strand RNA is then used as a
template to generate multiple copies of viral plus-strand
genomes that are translated into enteroviral structural pro-
teins and ultimately packaged into new virions. Therefore,
the detection of minus-strand enteroviral RNA is an indi-
cator of active enteroviral RNA replication (45). In this
study minus-strand enteroviral RNA was verified in seven
(78%) of nine plus-strand-positive patients. Therefore, our
findings indicate that enteroviruses replicate actively in the
myocardium in a significant proportion of cases of end-stage
idiopathic DCM. This finding is extremely important in the
investigation of the pathogenesis of and treatment for this
disease. The persistence of enteroviral-specific Ig M re-
sponse for many years in some patients with DCM was
reported (6). Muir et al. (46) reported that enteroviral-
specific IgM was detected in 22 (56%) of 39 patients with
end-stage DCM. These data also support the idea that
enterovirus persists in a replicative form in hearts with
DCM.
Wessely et al. (47) reported that only a low level of
expression of coxsackie B3 virus genome, not infectious
virus progeny, was sufficient to induce a cytopathic effect in
cultured neonatal rat ventricular myocytes. They also dem-
onstrated that the transgenic expression of replication-
restricted coxsackieviral genome in the heart could induce
DCM (48). By analysis of isolated myocytes from these
transgenic mice, defective-contraction coupling and a de-
crease in the magnitude of isolated cell shortening were
observed. In this study enterovirus was not isolated in cell
culture by conventional methods. It is possible that sequence
mutations could accumulate during productive virus repli-
cation in the early phase of the disease and that mutant
(defective virus) may appear in order to escape the host






(n 5 17) p Value
Age (yrs) 42.9 6 18.8 50.3 6 12.4 NS
Gender (male/female) 8/1 12/5 NS
NYHA functional class:
III 2 5 NS
IV 7 12
Echocardiographic data:
LVDd (mm) 80.4 6 7.9 79.9 6 11.1 NS
LVEF (%) 17.8 6 6.6 18.4 6 7.4 NS
Surgical data:
PLV
With MVP/MVR 9 16 NS
With TAP 4 7 NS
LVDd 5 left ventricular end-diastolic diameter; LVEF 5 left ventricular ejection fraction; MVP 5 mitral valve plasty; MVR
5 mitral valve replacement; NYHA 5 New York Heart Association; PLV 5 partial left ventriculectomy; TAP 5 tricuspid valve
plasty; NS 5 not significant.
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immune systems. These mutants may persist in replicative
form without formation of virus progeny, and restricted viral
RNA replication in the myocardium could be capable of
significantly impairing contractile function of the heart, as
was shown in transgenic mice (48). Considering the high
incidence of enteroviral positivity and active viral replication
in end-stage hearts with DCM, the examination of entero-
virus RNA in earlier stages of hearts with DCM would be
recommended. If enteroviral RNA, especially minus-strand
RNA, is demonstrated in the myocardium, an antiviral
agent to coxsackie B virus (agent for preventing viral RNA
replication) should be used for the management of this
disease.
Other cardiotropic viruses and DCM. Genomes of hep-
atitis C virus, cytomegalovirus and adenovirus were detected
in the myocardium of patients with DCM, and an associ-
ation between these viruses and DCM was suggested
(24,25,27). However, subsequent studies, including molec-
ular detection of these viruses in the myocardium, have not
been performed. In this study genomic materials of other
potentially cardiotropic viruses, including hepatitis C virus,
influenza viruses, mumps virus, adenovirus, cytomegalovi-
rus, herpes simplex viruses, varicella-zoster virus and
Epstein-Barr virus were not demonstrated. Therefore, per-
sistent infection of these viruses in the myocardium of
patients with DCM is unlikely. However, patients at earlier
stages of the disease should be examined. The persistence of
the immune response beyond clearance of the virus cannot
be completely ruled out.
Clinical outcomes after PLV. It seems necessary to exam-
ine the prognosis in response to PLV. Enterovirus RNA-
positive patients, especially minus-strand enteroviral RNA-
positive patients, had an increased mortality rate compared
with enterovirus RNA-negative patients. Several factors
affecting outcome must be considered to determine whether
enteroviral RNA, particularly minus-strand enteroviral
RNA in the myocardium, is a predictor of outcome after
PLV. There were no significant differences in preoperative
clinical features, the severity of the heart failure, cardiac
function or surgical results in enterovirus RNA-positive
versus enterovirus RNA-negative patients. Therefore, our
findings show that active coxsackieviral RNA replication in
the myocardium can be a marker for poor prognosis after
PLV.
Conclusions. Coxsackie B viruses were demonstrated in
the myocardium of patients with idiopathic DCM. Active
viral RNA replication in the myocardium appeared to be
present in a significant proportion of these cases. Minus-
strand coxsackieviral RNA in the myocardium can be a
marker for poor clinical outcome after PLV. Considering
these findings, an antiviral agent to coxsackie B virus should
be used for the management of this disease. There was no
evidence of persistent infection by other viruses, including
hepatitis C virus, cytomegalovirus and adenovirus, in hearts
with DCM.
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